HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K H Cheong Selected Research

SAIT301

4/2014Met degradation by SAIT301, a Met monoclonal antibody, reduces the invasion and migration of nasopharyngeal cancer cells via inhibition of EGR-1 expression.
1/2014Cbl-independent degradation of Met: ways to avoid agonism of bivalent Met-targeting antibody.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K H Cheong Research Topics

Disease

3Neoplasms (Cancer)
01/2016 - 01/2014
1Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
04/2014
1Squamous Cell Carcinoma of Head and Neck
04/2014
1Lymphoma (Lymphomas)
01/2014
1Otitis Media
09/2012

Drug/Important Bio-Agent (IBA)

2SAIT301IBA
04/2014 - 01/2014
1ErbB Receptors (EGF Receptor)IBA
01/2016
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
04/2014
1Monoclonal AntibodiesIBA
04/2014
1AntibodiesIBA
01/2014
1LigandsIBA
01/2014
1Proto-Oncogene Proteins c-metIBA
01/2014
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2014
1nitrosocobalaminIBA
01/2014
1Anti-Bacterial Agents (Antibiotics)IBA
09/2012

Therapy/Procedure

2Therapeutics
01/2016 - 01/2014
1Adenoidectomy
09/2012
1Middle Ear Ventilation (Tympanostomy)
09/2012